187 related articles for article (PubMed ID: 3653201)
1. The correlation between the spread of metastases by level in the axillary nodes and disease-free survival in breast cancer. A multifactorial analysis.
Gaglia P; Bussone R; Caldarola B; Lai M; Jayme A; Caldarola L
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):849-54. PubMed ID: 3653201
[TBL] [Abstract][Full Text] [Related]
2. Complete axillary lymph node dissection for stage I-II carcinoma of the breast.
Danforth DN; Findlay PA; McDonald HD; Lippman ME; Reichert CM; d'Angelo T; Gorrell CR; Gerber NL; Lichter AS; Rosenberg SA
J Clin Oncol; 1986 May; 4(5):655-62. PubMed ID: 3701387
[TBL] [Abstract][Full Text] [Related]
3. Discontinuous or "skip" metastases in breast carcinoma. Analysis of 1228 axillary dissections.
Rosen PP; Lesser ML; Kinne DW; Beattie EJ
Ann Surg; 1983 Mar; 197(3):276-83. PubMed ID: 6830335
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: patterns of recurrence.
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Venkatesan V; Dar AR; Stitt L
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):541-50. PubMed ID: 9231678
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
[TBL] [Abstract][Full Text] [Related]
6. Incidence and prognostic significance of complete axillary downstaging after primary chemotherapy in breast cancer patients with T1 to T3 tumors and cytologically proven axillary metastatic lymph nodes.
Rouzier R; Extra JM; Klijanienko J; Falcou MC; Asselain B; Vincent-Salomon A; Vielh P; Bourstyn E
J Clin Oncol; 2002 Mar; 20(5):1304-10. PubMed ID: 11870173
[TBL] [Abstract][Full Text] [Related]
7. The importance of extracapsular extension of axillary lymph node metastases in breast cancer.
Ilknur GB; Hilmi A; Tülay C; Oguz C; Selma S; Serdar S; Uğur Y; Pinar B; Omer H; Münir K;
Tumori; 2004; 90(1):107-11. PubMed ID: 15143982
[TBL] [Abstract][Full Text] [Related]
8. Association between extent of axillary lymph node dissection and survival in patients with stage I breast cancer.
Sosa JA; Diener-West M; Gusev Y; Choti MA; Lange JR; Dooley WC; Zeiger MA
Ann Surg Oncol; 1998 Mar; 5(2):140-9. PubMed ID: 9527267
[TBL] [Abstract][Full Text] [Related]
9. Extracapsular axillary node extension in patients receiving adjuvant systemic therapy: an indication for radiotherapy?
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Dar AR; Venkatesan VM; Stitt L; Radwan JS
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):551-9. PubMed ID: 9231679
[TBL] [Abstract][Full Text] [Related]
10. Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial.
Sávolt Á; Péley G; Polgár C; Udvarhelyi N; Rubovszky G; Kovács E; Győrffy B; Kásler M; Mátrai Z
Eur J Surg Oncol; 2017 Apr; 43(4):672-679. PubMed ID: 28139362
[TBL] [Abstract][Full Text] [Related]
11. Significance of axillary lymph node extranodal soft tissue extension and indications for postmastectomy irradiation.
Mignano JE; Zahurak ML; Chakravarthy A; Piantadosi S; Dooley WC; Gage I
Cancer; 1999 Oct; 86(7):1258-62. PubMed ID: 10506712
[TBL] [Abstract][Full Text] [Related]
12. Level of axillary involvement by lymph node metastases from breast cancer is not an independent predictor of survival.
Barth RJ; Danforth DN; Venzon DJ; Straus KL; d'Angelo T; Merino MJ; Gerber L
Arch Surg; 1991 May; 126(5):574-7. PubMed ID: 2021339
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of axillary node and infraclavicular lymph node status after mastectomy.
Kuru B; Camlibel M; Dinc S; Gulcelik MA; Alagol H
Eur J Surg Oncol; 2003 Dec; 29(10):839-44. PubMed ID: 14624774
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant tamoxifen alone: patterns of recurrence.
Fisher BJ; Perera FE; Cooke AL; Opeitum A; Stitt L
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):117-23. PubMed ID: 9747828
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
[TBL] [Abstract][Full Text] [Related]
16. Axillary lymph node involvement in stage III breast cancer: treatment implications.
Voss M; Schneider JW; Apffelstaedt J
J Surg Oncol; 1999 Jul; 71(3):162-6. PubMed ID: 10404132
[TBL] [Abstract][Full Text] [Related]
17. [Axillary skip metastases in breast cancer].
Sun JY; Ning LS
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):352-5. PubMed ID: 18953834
[TBL] [Abstract][Full Text] [Related]
18. Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastases.
Janni W; Rack B; Sommer H; Schmidt M; Strobl B; Rjosk D; Klanner E; Thieleke W; Gerber B; Friese K; Dimpfl T
J Cancer Res Clin Oncol; 2003 Sep; 129(9):503-10. PubMed ID: 12884027
[TBL] [Abstract][Full Text] [Related]
19. Locoregional failure of postmastectomy patients with 1-3 positive axillary lymph nodes without adjuvant radiotherapy.
Cheng JC; Chen CM; Liu MC; Tsou MH; Yang PS; Jian JJ; Cheng SH; Tsai SY; Leu SY; Huang AT
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):980-8. PubMed ID: 11958892
[TBL] [Abstract][Full Text] [Related]
20. [The effect of axillary lymph node status on the prognosis of patients with local-regional recurrence after breast-conserving surgery].
Zhang Z; Zhang W; Li ZJ; Wang XM; Cao XC; Xiao CH
Zhonghua Zhong Liu Za Zhi; 2018 May; 40(5):347-351. PubMed ID: 29860761
[No Abstract] [Full Text] [Related]
[Next] [New Search]
